351.09
Beone Medicines Ltd Adr stock is traded at $351.09, with a volume of 155.83K.
It is up +2.77% in the last 24 hours and up +1.34% over the past month.
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.
See More
Previous Close:
$341.62
Open:
$347.82
24h Volume:
155.83K
Relative Volume:
0.45
Market Cap:
$38.50B
Revenue:
$4.56B
Net Income/Loss:
$-176.77M
P/E Ratio:
-204.40
EPS:
-1.7177
Net Cash Flow:
$225.30M
1W Performance:
+4.75%
1M Performance:
+1.34%
6M Performance:
+67.66%
1Y Performance:
+0.00%
Beone Medicines Ltd Adr Stock (ONC) Company Profile
Name
Beone Medicines Ltd Adr
Sector
Industry
Phone
41-616851900
Address
C/O BEONE MEDICINES I GMBH, BASEL
Compare ONC with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
ONC
Beone Medicines Ltd Adr
|
351.09 | 37.52B | 4.56B | -176.77M | 225.30M | -1.7177 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
421.15 | 105.19B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
450.68 | 60.24B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
563.86 | 61.82B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
798.94 | 49.09B | 3.06B | 1.28B | 447.35M | 19.67 |
Beone Medicines Ltd Adr Stock (ONC) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Sep-18-25 | Initiated | Barclays | Overweight |
Apr-07-25 | Initiated | RBC Capital Mkts | Outperform |
Mar-03-25 | Upgrade | BofA Securities | Neutral → Buy |
Dec-03-24 | Resumed | Morgan Stanley | Overweight |
Sep-18-24 | Initiated | JMP Securities | Mkt Outperform |
Feb-06-24 | Resumed | JP Morgan | Overweight |
Sep-12-23 | Initiated | Macquarie | Outperform |
Aug-17-23 | Initiated | Jefferies | Buy |
Jul-17-23 | Initiated | Citigroup | Buy |
Jun-30-23 | Downgrade | Bernstein | Outperform → Mkt Perform |
Jan-12-23 | Initiated | Daiwa Securities | Buy |
Oct-13-22 | Upgrade | Guggenheim | Neutral → Buy |
Oct-13-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
Aug-09-22 | Resumed | JP Morgan | Overweight |
Mar-17-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
Feb-07-22 | Initiated | Deutsche Bank | Buy |
Oct-12-21 | Initiated | Bernstein | Outperform |
Oct-06-21 | Upgrade | CLSA | Underperform → Buy |
Mar-08-21 | Initiated | China Renaissance | Buy |
Mar-01-21 | Downgrade | CLSA | Outperform → Underperform |
Nov-09-20 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
Nov-06-20 | Downgrade | Maxim Group | Buy → Hold |
Nov-06-20 | Downgrade | Piper Sandler | Neutral → Underweight |
View All
Beone Medicines Ltd Adr Stock (ONC) Latest News
160 Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC Acquired by Farther Finance Advisors LLC - Defense World
Slow Capital Inc. Makes New Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Signaturefd LLC Purchases New Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
PFG Investments LLC Acquires Shares of 985 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
14,420 Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC Bought by Public Employees Retirement System of Ohio - Defense World
14,420 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Bought by Public Employees Retirement System of Ohio - MarketBeat
Perigon Wealth Management LLC Acquires New Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
LVW Advisors LLC Purchases Shares of 1,022 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines Ltd.Sponsored ADR (NASDAQ:ONC) Receives $336.30 Consensus PT from Brokerages - MarketBeat
Aaron Wealth Advisors LLC Invests $200,000 in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Brokerages Set BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) Target Price at $336.30 - Defense World
BeOne Medicines (NASDAQ:ONC) Shares Gap DownHere's What Happened - MarketBeat
John Oyler Sells 27,803 Shares of BeOne Medicines (NASDAQ:ONC) Stock - MarketBeat
Avanza Fonder AB Makes New $199,000 Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines (NASDAQ:ONC) Upgraded at Zacks Research - Defense World
BeOne Medicines (NASDAQ:ONC) Coverage Initiated by Analysts at Barclays - Defense World
BeOne Medicines (NASDAQ:ONC) SVP Sells 10,006 Shares - MarketBeat
BeOne Medicines (NASDAQ:ONC) Shares Gap UpHere's What Happened - MarketBeat
BeOne Medicines (NASDAQ:ONC) Insider Sells $1,750,300.00 in Stock - MarketBeat
BeOne Medicines (NASDAQ:ONC) Shares Gap Down After Insider Selling - MarketBeat
Beone Medicines Ltd Adr Stock (ONC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):